所有图片(1)
About This Item
经验公式（希尔记法）:
C5H10O4
CAS号:
分子量:
134.13
MDL编号:
UNSPSC代码:
12352201
PubChem化学物质编号:
NACRES:
NA.25
推荐产品
质量水平
方案
≥97.0% (TLC)
表单
powder
旋光性
[α]/D 54.0±2.0°, 24 hr, c = 1 in H2O
储存温度
2-8°C
SMILES字符串
O=CC[C@@H](O)[C@@H](O)CO
InChI
1S/C5H10O4/c6-2-1-4(8)5(9)3-7/h2,4-5,7-9H,1,3H2/t4-,5+/m1/s1
InChI key
ASJSAQIRZKANQN-UHNVWZDZSA-N
正在寻找类似产品? 访问 产品对比指南
生化/生理作用
Inhibitor of enzymes and valuable building block for synthesis
其他说明
To gain a comprehensive understanding of our extensive range of Monosaccharides for your research, we encourage you to visit our Carbohydrates Category page.
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
监管及禁止进口产品
Aqeel Ahmed et al.
Journal of the American Chemical Society, 128(44), 14224-14225 (2006-11-02)
The reaction of 70 unprotected, diversely functionalized free reducing sugars with methoxyamine-appended colchicine led to the production of a 58-member glycorandomized library. High-throughput cytotoxicity assays revealed glycosylation to modulate specificity and potency. Library members were also identified which, unlike the
Masao Shiozaki et al.
Carbohydrate research, 370, 46-66 (2013-03-05)
KRN7000 is one of the α-galactosylceramides, which has a 2-hexacosanoylamino-3,4-dihydroxyoctadecyl group. This compound, known as a ligand for the activation of CD1d mediated invariant natural killer T cells (iNKT cells) which release both T helper 1 (Th1) cytokines such as
Warfarin glycosylation invokes a switch from anticoagulant to anticancer activity.
Pauline Peltier-Pain et al.
ChemMedChem, 6(8), 1347-1350 (2011-06-30)
Yuichi Nakajima et al.
Cancer research, 64(5), 1794-1801 (2004-03-05)
Thymidine phosphorylase (TP) catalyzes the reversible conversion of thymidine to thymine, thereby generating 2-deoxy-D-ribose-1-phosphate, which upon dephosphorylation forms 2-deoxy-D-ribose (D-dRib), a degradation product of thymidine. We have previously shown that D-dRib promotes angiogenesis and chemotaxis of endothelial cells and also
Serkan Dikici et al.
Microvascular research, 131, 104035-104035 (2020-07-01)
Delayed neovascularisation of tissue-engineered (TE) complex constructs is a major challenge that causes their failure post-implantation. Although significant progress has been made in the field of angiogenesis, ensuring rapid neovascularisation still remains a challenge. The use of pro-angiogenic agents is
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门